Elevance Health, Inc. ELV
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.12% | -7.41% | -11.39% | -5.32% | -13.79% |
| Total Depreciation and Amortization | -14.68% | -4.83% | 3.28% | 12.75% | 9.54% |
| Total Amortization of Deferred Charges | 9.40% | 9.40% | 9.40% | 9.40% | 7.15% |
| Total Other Non-Cash Items | -311.11% | -211.45% | -3,127.27% | 133.12% | 74.36% |
| Change in Net Operating Assets | 181.56% | 283.06% | 146.42% | -90.63% | 54.25% |
| Cash from Operations | 54.64% | 15.65% | 56.90% | -26.14% | 130.50% |
| Capital Expenditure | 5.50% | -5.19% | 1.53% | 11.15% | 9.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.96% | 101.07% | 102.42% | 101.83% | -228.21% |
| Divestitures | -- | -- | -- | -- | -109.02% |
| Other Investing Activities | -243.52% | -151.23% | -216.20% | -159.07% | 152.68% |
| Cash from Investing | 12.77% | 14.49% | -12.16% | 73.99% | 24.40% |
| Total Debt Issued | -70.49% | -1.91% | -11.90% | -22.43% | 194.31% |
| Total Debt Repaid | 52.53% | -68.54% | -38.97% | -54.80% | -771.53% |
| Issuance of Common Stock | 274.36% | 39.08% | -35.37% | -63.35% | -84.08% |
| Repurchase of Common Stock | 44.84% | 14.09% | 16.50% | 12.30% | -87.52% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.70% | 0.99% | -0.26% | -1.39% | -2.97% |
| Other Financing Activities | 766.67% | 347.06% | 306.25% | 1,000.00% | -72.73% |
| Cash from Financing | -418.55% | -104.76% | -213.37% | -245.68% | 7.06% |
| Foreign Exchange rate Adjustments | -185.71% | -2,000.00% | -200.00% | 16.67% | -333.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -130.00% |
| Net Change in Cash | 93.03% | -18.95% | 69.31% | -31.73% | 127.74% |